Evaluation of time, Attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: The DEGRO-QUIRO trial

Strahlentherapie und Onkologie

Volumn 187, Issue 8, 2011, Pages 449-460

  Budach, Wilfried ^a   Bölke, Edwin ^a   Fietkau, Rainer ^b   Buchali, Andre ^c   Wendt, Thomas G ^d   Popp, Wolfgang ^e   Matuschek, Christiane ^a   Sack, Horst ^f  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Hospital Neuruppin   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e Prime Networks AG   (Switzerland)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Head and neck cancer; Medical staff; Radiotherapy; Resources; Time requirement

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK CANCER; HEALTH CARE MANPOWER; HEALTH CARE PLANNING; HOSPITAL BED UTILIZATION; HUMAN; MANPOWER PLANNING; MEDICAL STAFF; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOLOGICAL TECHNOLOGIST; SIMULATION; TREATMENT PLANNING; WORKING TIME;

APPOINTMENTS AND SCHEDULES; BED OCCUPANCY; CONTRAST MEDIA; GERMANY; HUMANS; MEDICAL STAFF, HOSPITAL; OTORHINOLARYNGOLOGIC NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; RADIOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SOCIETIES, MEDICAL; TIME AND MOTION STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80052262320     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2273-z     Document Type: Article

References (23)

1. S.M. Bentzen G. Heeren B. Cottier, et al. 2005 Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project Radiother Oncol 75 355 365 16086915 10.1016/j.radonc.2004. 12.007 (Pubitemid 41007983)
2. B. Berger C. Belka M. Weinmann, et al. 2010 Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol Strahlenther Onkol 186 255 261 20437016 10.1007/s00066-010-2082-9
3. J. Bernier J.C. Horiot H. Bartelink, et al. 1996 Profile of radiotherapy departments contributing to the Cooperative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer Int J Radiat Oncol Biol Phys 34 953 960 8598375 10.1016/0360-3016(95)02177-9 1:STN:280: DyaK287nsFaktQ%3D%3D (Pubitemid 26089235)
4. P. Boyle A. d'Onofrio P. Maisonneuve, et al. 2003 Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? Ann Oncol 14 1312 1325 12881398 10.1093/annonc/mdg353 1:STN:280: DC%2BD3szkvVejsQ%3D%3D (Pubitemid 37039061)
5. N. Dinapoli C. Parrilla J. Galli, et al. 2010 Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population Strahlenther Onkol 186 607 613 21069268 10.1007/s00066-010-2142-1
6. R. Esco A. Palacios J. Pardo, et al. 2003 Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources Int J Radiat Oncol Biol Phys 56 319 327 12738304 10.1016/S0360-3016(02)04580-7 1:STN:280: DC%2BD3s3hslCmsQ%3D%3D (Pubitemid 36542888)
7. K. Lang M. Sussman M. Friedman, et al. 2009 Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck Arch Otolaryngol Head Neck Surg 135 582 588 19528407 10.1001/archoto.2009.46
8. A. Norlund 2003 Costs of radiotherapy Acta Oncol 42 411 415 14596503 10.1080/02841860310011140 (Pubitemid 37193834)
9. A. acios Eito M. Espinosa Calvo A. Manas Rueda, et al. 2008 Radiation oncology: future needs and equipment. Current situation in Spain Clin Transl Oncol 10 478 485 10.1007/s12094-008-0236-3
10. R. Peto J. Boreham M. Clarke, et al. 2000 UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years Lancet 355 1822 10832853 10.1016/S0140-6736(00)02277-7 1:STN:280:DC%2BD3c3ptVCmsg%3D%3D (Pubitemid 30265099)
11. N. Platteaux P. Dirix B. Vanstraelen, et al. 2011 Outcome after re-irradiation of head and neck cancer patients Strahlenther Onkol 187 23 31 21234530 10.1007/s00066-010-2139-9
12. N. Ploquin P. Dunscombe 2009 A cost-outcome analysis of image-guided patient repositioning in the radiation treatment of cancer of the prostate Radiother Oncol 93 25 31 19409635 10.1016/j.radonc.2009.03.023
13. N.P. Ploquin P.B. Dunscombe 2008 The cost of radiation therapy Radiother Oncol 86 217 223 18237802 10.1016/j.radonc.2008.01.005
14. S. Ruggieri-Pignon T. Pignon M. Marty, et al. 2005 Infrastructure of radiation oncology in France: a large survey of evolution of external beam radiotherapy practice Int J Radiat Oncol Biol Phys 61 507 516 15667974 10.1016/j.ijrobp.2004.06.009 (Pubitemid 40164448)
15. T. Satoh H. Ishiyama K. Matsumoto, et al. 2009 Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience Jpn J Radiol 27 348 354 19943145 10.1007/s11604-009-0356-x
16. S. Semrau F. Waldfahrer M. Lell, et al. 2011 Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue: early results Strahlenther Onkol 187 15 22 21234526 10.1007/s00066-010-2178-2
17. B.J. Slotman B. Cottier S.M. Bentzen, et al. 2005 Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1 Radiother Oncol 75 349 354 15893832 10.1016/j.radonc.2004.12.005 (Pubitemid 41007982)
18. B.J. Slotman J.W. Leer 2003 Infrastructure of radiotherapy in the Netherlands: evaluation of prognoses and introduction of a new model for determining the needs Radiother Oncol 66 345 349 12742276 10.1016/S0167-8140(03) 00025-2 (Pubitemid 36556054)
19. M. Talback M. Stenbeck M. Rosen, et al. 2003 Cancer survival in Sweden 1960-1998-developments across four decades Acta Oncol 42 637 659 14690151 10.1080/02841860310013391 (Pubitemid 37445286)
20. S. Tribius S. Kronemann Y. Kilic, et al. 2009 Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck Strahlenther Onkol 185 675 681 19806333 10.1007/s00066-009-1992-x
21. W.A. van Daal M.A. Bos 1997 Infrastructure for radiotherapy in The Netherlands: development from 1970 to 2010 Int J Radiat Oncol Biol Phys 37 411 415 9069315 10.1016/S0360-3016(96)00514-7 (Pubitemid 27138727)
22. E. Van der Werf Y. Lievens J. Verstraete, et al. 2009 Time and motion study of radiotherapy delivery: economic burden of increased quality assurance and IMRT Radiother Oncol 93 137 140 19732984 10.1016/j.radonc.2009.07.007
23. H.A. Wolff J. Bosch K. Jung, et al. 2010 High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer Strahlenther Onkol 186 262 268 20437012 10.1007/s00066-010-2136-z